Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lung Master Protocol (Lung-MAP)—A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400

14 Feb 2015

Abstract excerpt

The Lung Master Protocol (Lung-MAP, S1400) is a groundbreaking clinical trial designed to advance the efficient development of targeted therapies for squamous cell carcinoma (SCC) of the lung. There are no approved targeted therapies specific to advanced lung SCC, although The Cancer Genome Atlas project and similar studies have detected a significant number of somatic gene mutations/amplifications in lung SCC,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Lung Cancer Research Studies
Share to Lung Cancer Treatments and Mutations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25680375
DOI: 10.1158/1078-0432.ccr-13-3473

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lung Master Protocol (Lung-MAP)—A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400PMID 25680375Read ↗

Innovative Clinical Trials: The LUNG-MAP Study.Semantic proximity Read ↗

Squamous cell lung cancer: from tumor genomics to cancer therapeutics.Semantic proximity Read ↗

SCLC TumorMiner: A Genomics Platform for Small Cell Lung Cancer Precision OncologySemantic proximity Read ↗

Clinical application of the Lung Cancer Compact PanelTM using various types of cytological specimens in patients with lung cancer.Semantic proximity Read ↗

New strategies in squamous cell carcinoma of the lung: identification of tumor drivers to personalize therapy.Semantic proximity Read ↗

The National Lung Matrix Trial of personalized therapy in lung cancer.Semantic proximity Read ↗

Lung-MAP Next-Generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers (SWOG S1400).Semantic proximity Read ↗

Next-generation sequencing informs diagnosis and identifies unexpected therapeutic targets in lung squamous cell carcinomas.Semantic proximity Read ↗

Personalized therapy on the horizon for squamous cell carcinoma of the lung.Semantic proximity Read ↗

Targeted therapies for locally advanced or metastatic squamous cell carcinoma of the lung.Semantic proximity Read ↗

[Biomarker analysis from a pathologist's view. Founding the rationale for personalised treatment of lung cancer].Semantic proximity Read ↗

Mastering the Complex Targeted Therapy for Non-small Cell Lung Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.